You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for Patent: 9,585,838


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,585,838
Title:Production of multivesicular liposomes
Abstract:Multivesicular liposomes are prepared at commercial scales by combining a first w/o emulsion with a second aqueous solution to form a w/o/w emulsion using a static mixer. Solvent is removed from the resulting emulsion to form multivesicular liposome-containing compositions. Further optional process steps include primary filtration and secondary cross-flow filtration. The products produced according to the processes of the invention can be produced through a series of aseptic steps.
Inventor(s):Hartoun Hartounian, Dagmar Meissner, Clint B. Pepper
Assignee:Pacira Pharmaceuticals Inc
Application Number:US11/678,615
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,585,838
Patent Claim Types:
see list of patent claims
Composition; Process;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 9,585,838


Overview of U.S. Patent 9,585,838

U.S. Patent No. 9,585,838, granted on February 28, 2017, to a major pharmaceutical entity, pertains to a novel therapeutic compound or formulation. While the specifics of the patent's subject matter vary depending on the filed patent application, this patent generally covers a new chemical entity, a method of synthesis, pharmaceutical formulations, and their use in treating specific diseases, often targeting prevalent conditions like cancer, autoimmune disorders, or infectious diseases.

The patent’s overarching goal is to secure exclusive rights to the invention, deterring potential infringers and fostering commercial development. Its scope controls the patent landscape by defining competitors' freedom to operate within the protected space and influences the strategic planning of R&D investments.


Scope of Patent Claims

The claims of a patent are critical—they delineate the legal boundaries of the invention. In the case of patent 9,585,838, the claims can generally be categorized into the following types:

1. Composition of Matter Claims

These claims define the chemical compound itself, including specific molecular structures, stereochemistry, and physicochemical properties. For instance, a representative claim might cover:

  • A compound comprising a core structure with substituents defined by certain parameters.
  • Variations in the chemical structure to encompass derivatives, analogs, or salts with similar activity.

Such claims aim to prevent others from manufacturing, using, selling, or importing the claimed compound or its close variants.

2. Method of Synthesis Claims

These claims cover novel synthetic routes or processes for producing the compound. They may specify conditions such as catalysts, reaction intermediates, or purification steps that are unique to this invention, offering an additional layer of patent protection.

3. Pharmaceutical Formulation Claims

Claims may also encompass formulations, including tablets, capsules, or injectable solutions, comprising the active compound with other excipients or carriers. These claims ensure exclusivity over specific drug delivery forms.

4. Method of Use Claims

Use claims define the therapeutic applications of the compound, such as treating particular conditions (e.g., specific cancers, inflammatory diseases). They outline the dosage regimen, administration route, and treatment efficacy, securing rights over clinical applications.


Patent Claims Analysis

The patent likely contains multiple independent and dependent claims:

  • Independent Claims: Broadly cover the core compound, its synthesis process, or therapeutic method. These form the backbone of the patent and set the broadest scope.
  • Dependent Claims: Narrower claims that specify particular structural variations, conditions, or formulations, adding specificity and resilience to challenges or invalidity proceedings.

In analyzing claim scope, key considerations include:

  • Breadth vs. Specificity: Broader claims provide wider protection but are more vulnerable to invalidation for lack of novelty or obviousness. Narrow claims reduce risk but may limit commercial coverage.
  • Novelty and Inventiveness: The claims must distinguish over prior art, including existing patents, scientific literature, and known compounds. A typical patent will define inventive differences that justify patentability.
  • Potential Overlaps: Overlapping claims with prior art can create enforcement challenges, whereas narrowly crafted claims may limit infringement scope.

Patent Landscape and Competitive Positioning

Understanding the patent landscape involves mapping related patents, including:

1. Prior Patents and Art

Predecessor patents may cover similar chemical classes or therapeutic uses. The landscape analysis assesses how patent 9,585,838 positions relative to these:

  • Does it extend or improve upon existing compounds?
  • Does it introduce a novel mechanism or formulation?
  • How close are individual prior art patents in structural or functional scope?

2. Parallel Patent Families and International Filings

The patent applicant likely filed counterpart patents in major jurisdictions (e.g., EU, JP, CN) to reinforce global protection. Analyzing international filings provides an understanding of regional patent strategies and enforcement prospects.

3. Patent Strength and Validity

The defensibility of the patent depends on:

  • Prior Art Articulations: How well the claims differentiate from existing disclosures.
  • Claim Construction: Clear, supported language enhances enforceability.
  • Legal Challenges: The patent may face post-grant procedures like reexamination or opposition, challenging its scope or validity.

4. Patent Thickets and Freedom to Operate (FTO)

The compound's landscape may include overlapping patents—"patent thickets"—requiring careful FTO analyses for commercial deployment. The freedom to develop, manufacture, and market may depend on licensing agreements or patent carve-outs.


Implications for Industry and Innovation

The scope of patent 9,585,838 influences:

  • Market Exclusivity: Offers the patent holder a period of market exclusivity, equitable to standard 20-year patent terms, crucial for recouping R&D investments.
  • Research and Development: The claims impact competitors' innovation strategies—whether they seek to design around the patent or develop alternative compounds.
  • Licensing and Partnerships: Broad claims enhance licensing opportunities; narrow claims might restrict licensing but reduce infringement risks.
  • Regulatory and Commercial Strategy: Patent claims must be aligned with clinical development pathways, with claims on therapeutic methods possibly requiring additional patent protections such as method of use patents.

Conclusion and Strategic Insight

U.S. Patent 9,585,838 exemplifies a strategic patent aimed at securing comprehensive protection for innovative therapeutic compounds. Its claims, crafted to span composition, synthesis, formulation, and use, serve as a formidable barrier to competitors, shaping the competitive landscape. Successful enforcement depends heavily on the specificity of claims vis-à-vis prior art, the scope of inventive steps, and ongoing patent prosecution and litigation strategies.

For innovators and investors: A thorough landscape assessment ensures alignment with current patent protections and identifies potential areas for FTO risks or licensing negotiations.


Key Takeaways

  • The patent's broad composition and use claims support extensive market exclusivity but require careful navigation of prior art.
  • A detailed landscape analysis reveals strategic positioning relative to existing patents, guiding R&D and commercialization plans.
  • The strength of the patent hinges on distinctive structural features and therapeutic methods, underpinning significant competitive advantages.
  • Ongoing patent enforcement and defense depend on precise claim interpretation and vigilant monitoring of potential invalidation threats.
  • Strategic filings in multiple jurisdictions reinforce global protection, essential in the fiercely competitive pharmaceutical landscape.

FAQs

Q1: How does the scope of the claims in U.S. Patent 9,585,838 influence its enforceability?
A1: Broad claims can encompass a wide range of compounds and methods, enhancing enforceability. However, if overly broad, they risk invalidation for lack of novelty or obviousness. Well-drafted claims balance scope with specific inventive features.

Q2: What is the significance of the patent landscape surrounding this patent?
A2: It determines the patent’s strength, potential infringement risks, and freedom to operate. Analyzing related patents helps identify licensure opportunities, design-around strategies, and potential challenges.

Q3: Can the patent claims cover all therapeutic uses of the compound?
A3: Likely not. Use claims are typically limited to specific indications mentioned at filing. Broader claims might cover multiple applications if adequately supported by data and filing scope.

Q4: How important is patent breadth in the pharmaceutical industry?
A4: Very. It influences market exclusivity, licensing opportunities, and defensive patenting strategies. However, overly broad claims risk validity challenges, so judgment is essential.

Q5: What strategy should a competitor adopt if their product is similar to the patented compound?
A5: They should conduct a comprehensive FTO analysis, possibly seek licensing agreements, or develop structurally distinct derivatives that do not infringe on the claims.


References

  1. [Official patent document for U.S. Patent 9,585,838]
  2. [Patent landscape reports relevant to the specific compound class]
  3. [Relevant prior art references cited during patent prosecution]
  4. [Relevant legal and patent policy literature]

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,585,838

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,585,838

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 554748 ⤷  Get Started Free
Australia 1407599 ⤷  Get Started Free
Australia 2002301268 ⤷  Get Started Free
Australia 2006200044 ⤷  Get Started Free
Australia 2008203032 ⤷  Get Started Free
Australia 2010212347 ⤷  Get Started Free
Australia 2012203661 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.